Although the number of specialty drug approvals is increasing, there is still much work to be done in the specialty area, especially in rare diseases and non-alcoholic steatohepatitis (NASH). During the keynote session at the Nexus 2023 Academy of Managed Care Pharmacy conference, Aimee Tharaldson, PharmD, clinical program principal of Emerging Therapies at Evernorth, discussed … Read more
Wall Street falters after mixed earnings reports NEW YORK Wall Street fell on October 18 after rising Treasury yields tightened pressure on the stock market and major US companies issued a series of mixed profit reports. Worries about war in the Middle East also pulled the market down. The S&P 500 index fell 1.3% on … Read more
In the face of continuing global geopolitical instability, Europe is increasingly paying attention to its sovereignty, security and resilience. The availability of vital medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, policies that can build health resilience and strengthen health systems are coming into … Read more
The rapid rise of the weight loss drug GLP-1 is likely to create a major stir in the stock market. The long-term ripple effects of these drugs will impact sectors of the stock market and the economy. These are areas to watch as drugs like Ozempic, Wegovy and Mounjaro grow in popularity. Loading Something is … Read more